Comparison · SL6733 vs Snomax

Snomax alternative, engineered from the polymer up.

Snomax is the biological snowmaking nucleator that has dominated the market for three decades — and is restricted across France (2005 moratorium), Austria, and Bavaria. SL6733 is being engineered as the synthetic, EU-compliant alternative. Side-by-side, here is what changes.

TL;DR

Snomax is a biological product (inactivated Pseudomonas syringae) subject to national moratoriums in France (2005), Austria, and Bavaria. SL6733 is a synthetic polymer additive (ultra-high-MW polyacrylamide-co-acrylate + cold-water-swelling starch), engineered to qualify under the EU polymer exemption and US TSCA frameworks, with a +3°C wet-bulb advantage at a 6–7.6 ppm operational dose.

DimensionSnomaxSL6733
TypeBiological nucleator (inactivated Pseudomonas syringae)Synthetic polymer additive (polyacrylamide-co-sodium acrylate + starch)
Regulatory status (EU)Restricted: France (2005 moratorium), Austria, BavariaEngineered to qualify under EU polymer exemption
Regulatory status (US)Approved under biological frameworksPolyacrylamide is TSCA-listed
MechanismIce nucleation (raises freezing onset)Combined: distributed nucleation + ice recrystallization inhibition (IRI)
Wet-bulb advantageMarginal improvement at ice-nucleation onsetEngineered for +3°C wet-bulb gain
Snow yieldImprovement vs. plain water at sub-optimal tempsModelled 30–50% more snow per cubic metre of water
Snow quality (IRI)No IRI mechanism — relies on nucleation aloneActive IRI from COO− carboxylate groups → denser, slower-melting snow
Operational dosePackaged by nucleating activity (kg/ML water)6–7.6 ppm (mass-based, predictable)
Equipment compatibilityDrop-in for most existing systemsDrop-in for any existing system, any water source
Watershed safetyLive biological precursor; regulated as such<0.01% residual acrylamide; biodegradable starch + polymer chemistry
StatusCommercial, ~30 yearsEU lab pilots targeted 2026/27; commercial 2027/28

Run an SL6733 lab pilot next season.

EU resorts: pilot-cohort slots for 2026/27 include integration setup, on-site dosing, and operator training. Limited places.